Christopher R. D’Angelo, MD, discusses emerging therapies in diffuse large B-cell lymphoma.
Christopher R. D’Angelo, MD
Advertisement
Articles by Christopher R. D’Angelo, MD
Christopher R. D’Angelo, MD, discusses factors that determine whether CAR T-cell therapy or autologous stem cell transplant should be used in patients with relapsed/refractory diffuse large B-cell lymphoma.
Christopher R. D’Angelo, MD, discusses the potential drawbacks of 5-drug combinations in B-cell lymphoma.
Christopher R. D’Angelo, MD, discusses novel therapeutics under investigation in patients with diffuse large B-cell lymphoma.
Christopher R. D’Angelo, MD, discusses sequencing therapies for patients with lymphoma.
Christopher R. D’Angelo, MD, discusses advances made with CAR T-cell therapy in lymphoma.
Advertisement
Latest Updated Articles
Dr. D’Angelo on Selecting CAR T-Cell Therapy or Transplantation in DLBCLPublished: May 4th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
2
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
3
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
4
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
5